Skip to content

clinical finding

SenePlex+ Evening Moisturizer Normal to Dry — surface-renewal study

in the study

SenePlex+® Evening Moisturizer Normal to Dry

what it showed

Visible surface-cell turnover progressed from 49% greater at day 13 to 80% at day 16, 94% at day 17, and up to 100% greater by day 18; mean full visible turnover was 15.5 days versus 18.0 days for untreated skin.

In the 20-day study, visible surface-cell turnover increased progressively and reached up to 100% greater turnover than untreated skin by Day 18.

The measured change supports a fresher, smoother-looking skin surface over the study period.

What supports SenePlex+ Evening Moisturizer Normal to Dry?

8 details
How it was evaluated
Dansyl-chloride visual scoring of treated and untreated sites on the same subjects
Who took part
34 enrolled; 33 completed
Statistical context
Significant versus control on days 2–18; headline and mean-time comparisons p<0.001
Information checked
2026-08-03

Measured results · 20-day study

Skin cell renewal

In a 20-day independent clinical study of 33 women ages 19–65, measured by expert clinical grading compared with baseline, Evening Moisturizer – Normal to Dry with SenePlex+® and orchid stem cells accelerated skin cell renewal by 35.7%.

When it was measured
20-day study

Mean time to full visible surface turnover

15.5 ± 0.4 days treated vs 18.0 ± 0.4 days control

In the independent 20-day study of Evening Moisturizer – Normal to Dry with SenePlex+® in 33 women ages 19–65, assessed by dansyl-chloride scoring, mean time to full visible surface turnover was 15.5 ± 0.4 days at the treated site versus 18.0 ± 0.4 days at the untreated control site.

When it was measured
20-day study

Measured results · 18 days; 20-day study

100% cell renewal

In a 20-day independent clinical study of 33 women ages 19–65, measured by expert clinical grading compared with baseline, Evening Moisturizer – Normal to Dry with SenePlex+® and orchid stem cells achieved 100% cell renewal in 18 days, against a typical skin-renewal cycle of 28 or more days.

When it was measured
18 days; 20-day study

Measured results · 20-day study; day-13 endpoint

Surface-cell turnover

49% greater

The treated SenePlex+ formula site showed 49% greater visible surface-cell turnover than the untreated control site at day 13.

What was measured
visible surface-cell turnover
When it was measured
20-day study; day-13 endpoint

Measured results · 20-day study; day-16 endpoint

Surface-cell turnover

80% greater

The treated SenePlex+ formula site showed 80% greater visible surface-cell turnover than the untreated control site at day 16.

What was measured
visible surface-cell turnover
When it was measured
20-day study; day-16 endpoint

Measured results · 20-day study; day-17 endpoint

Surface-cell turnover

94% greater

The treated SenePlex+ formula site showed 94% greater visible surface-cell turnover than the untreated control site at day 17.

What was measured
visible surface-cell turnover
When it was measured
20-day study; day-17 endpoint

Measured results · 20-day study; day-18 endpoint

Surface-cell turnover

up to 100% greater

In an independent 20-day study, Evening Moisturizer – Normal to Dry with SenePlex+® showed up to 100% greater visible surface-cell turnover than untreated skin by day 18.

What was measured
visible surface-cell turnover
When it was measured
20-day study; day-18 endpoint

Mean residual dansyl-chloride surface-stain intensity

0.00 treated vs 0.18 untreated

At day 18, mean residual surface-stain intensity was 0.00 at the treated site versus 0.18 at the untreated control site; lower values indicate faster clearance.

When it was measured
20-day study; day-18 endpoint